Hallmark #11 of 12
When the microbiome turns against you
Your gut hosts 38 trillion microorganisms — more than your own cells. By age 70, microbial diversity drops ~30%, SCFA production collapses, and gut permeability rises, flooding the body with bacterial endotoxins that drive systemic inflammation.
Dysbiosis
The gut is a systems multiplier: it directly controls ∼70% of systemic serotonin (affecting mood and gut motility), trains 70% of the immune system (gut-associated lymphoid tissue), and modulates systemic NAD+ availability via microbial synthesis. A single course of broad-spectrum antibiotics can reduce microbiome diversity by 50% with incomplete recovery over 1–2 years, illustrating how fragile this system is. Food-first is non-negotiable: no compound in the TNiC library corrects the metabolic dysfunction caused by sub-25g/day fiber intake — diverse plant foods must come before any supplement consideration.
3 compound interventions · 4 trackable biomarkers
Top interventions
- ADiverse fiber / prebiotics
- AFermented foods (6 servings/day)
- BSulforaphane (gut NRF2 + barrier)
- BOmega-3 (EPA/DHA gut barrier)
- BTargeted probiotics
The Mechanism
The gut-inflammaging axis — three failure cascades
Aging microbiome shifts follow a predictable pattern: Faecalibacterium prausnitzii (the primary butyrate producer and anti-inflammatory organism) and Bifidobacterium (short-chain fatty acid producer, barrier maintainer) decline. Proteobacteria (gram-negative LPS-rich bacteria) expand. The result: less butyrate to fuel colonocytes, more LPS to trigger systemic TLR4 activation.
Leaky gut follows: tight junction proteins (ZO-1, occludin) require butyrate for expression. As SCFA production falls, tight junctions weaken. Bacterial LPS and peptidoglycans translocate into portal circulation — driving hepatic NF-κB activation, systemic IL-6 production, and metabolic endotoxemia.
The gut also produces ~90% of systemic serotonin and hosts the enteric nervous system — 500 million neurons communicating bidirectionally with the brain via the vagus nerve. Dysbiosis disrupts gut-brain axis signaling, driving neuroinflammation, altered mood, and impaired cognitive function independently of systemic cytokine effects.
The microbiome also regulates NAD+ metabolism via the kynurenine pathway. Age-related dysbiosis shifts tryptophan metabolism away from serotonin/NAD+ production toward inflammatory kynurenines — reducing NAD+ precursor availability and amplifying neuroinflammation simultaneously.
Monitoring
Gut health biomarkers
Evidence-Graded Interventions
Microbiome restoration with clinical evidence
Diverse fiber / prebiotics
Tier A30+ plant species per week feeds SCFA-producing taxa (F. prausnitzii, Bifidobacterium) that produce butyrate — the primary colonocyte fuel and NF-κB suppressor via HCAR2/GPR109a. Strongest, most replicable gut intervention available.
Fermented foods (6 servings/day)
Tier AStanford RCT (n=36, Cell 2021, PMID 34256014): 10-week high-fermented-food diet increased microbiome diversity 26% and reduced 19 inflammatory proteins including IL-6 and IL-12 — outperforming a matched high-fiber group for anti-inflammatory remodeling. Kefir, kimchi, sauerkraut, yogurt all qualify.
Sulforaphane (gut NRF2 + barrier)
Tier BNRF2 activation in gut epithelium upregulates tight-junction proteins (claudin-1, ZO-1) in preclinical models; reduces LPS-driven NF-κB activation in gut macrophages. The most relevant TNiC compound for gut barrier support.
Omega-3 (EPA/DHA gut barrier)
Tier BEPA and DHA reduce intestinal permeability by modulating tight junction expression, shift microbiota composition toward anti-inflammatory species, and reduce LPS translocation. Strong mechanistic + observational data; randomized human gut-specific trials emerging.
Targeted probiotics
Tier BAkkermansia muciniphila (Pendulum) and Bifidobacterium longum strains show promise in improving barrier function and reducing metabolic endotoxemia in pilot RCTs. Strain-specific — random multi-strain products have minimal replication.
Microbiome testing
Tier BViome, Thorne Onegevity, or clinical metagenomics (Genova, Doctor's Data) to baseline diversity and track intervention response at 8–12 weeks. Useful for identifying SIBO, Akkermansia deficit, or dysbiosis-specific interventions.
Rebuild your microbiome.
30 plant species a week + daily fermented foods is the highest-ROI gut intervention. Sulforaphane protects the barrier. Track zonulin in the Labs.